John H. Durham, United States Attorney for the District of Connecticut, announced that THOMAS MALONE, 49, of New Haven, was sentenced today by U.S. District Judge Janet Bond Arterton in New Haven to 24 months of imprisonment, followed by three years of supervised release, for embezzling approximately $1 million from a New Haven biotech company that receives federal research grants. According to court documents and statements made in court, Malone was the chief financial officer (CFO) of Artificial Cell Technologies, Inc. (ACT) of New Haven, a small biotech company that is currently working on developing better ways to deliver malaria and Respiratory Syncytial Virus vaccines to affected populations. In addition to receiving funding from private investors, ACT has received approximately $4.1 million in grants from the National Institutes of Health (NIH) since 2008. As the CFO, Malone’s responsibilities included collecting, posting and depositing investor and grant funds; tra...